Q1 2022 GlaxoSmithKline PLC Earnings Call Transcript
Good afternoon, ladies and gentlemen, and welcome to the Analyst Call for the GSK First Quarter 2022 Results. I will now hand you over to Nick Stone, Head of Global Investor Relations, who will introduce today's session.
Thank you, operator. Hello, everyone. Welcome to our Q1 2022 conference call and webcast for investors and analysts. The presentation was posted to gsk.com, and it was also sent by e-mail to our distribution list earlier today.
Please turn to Slide 2. This is the usual safe harbor statement, and we'll be making comments on our performance using constant exchange rates, or CER, unless otherwise stated.
Please turn to Slide 3. This is today's agenda, where we will plan to cover all aspects of our Q1 2022 results. The presentation will last approximately 25 minutes with a further 35 minutes for questions. (Operator Instructions)
Today, our speakers are Emma Walmsley; Luke Miels; Deborah Waterhouse; Brian McNamara; and Iain Mackay. The Q&A portion of the call will be joined by Hal Barron; Roger Connor; and David
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |